HIGHLIGHTS
- who: Kaylee M. Keller from the Princess Mu00e1xima Center for Pediatric Oncology, Utrecht, the Department of Pharmaceutical Sciences, University Utrecht, Utrecht, the have published the Article: The potential of PARP as a therapeutic target across pediatric solid malignancies, in the Journal: (JOURNAL)
- what: Due to the limited number of patients target and drug development for pediatrics is often supplemented by data from studies focused on adult cancers. Methods Using the publicly available Genomics of Drug Sensitivity in database the authors explore therapeutic targets and biomarkers specific to the pediatric solid malignancies Ewing sarcoma medulloblastoma neuroblastoma . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.